Ike Isaacson Advocates for Important Legislation in Washington D.C.

Published in Government Relations on January 19, 2024

Ike Isaacson and Rep. Guthrie

Ike Isaacson, SVP Government & Regulatory Relations, recently spent two days meeting with congressional offices in Washington, D.C. During these House and Senate meetings, Ike continued VGM’s work on strengthening support for S. 1294 and H.R. 5555, both of which contain language that would reinstate the higher 75/25 blended reimbursement rates that were in place for Medicare claims in non-rural, non-competitive bid areas from March 2020 through Dec. 31, 2023. If passed, the reinstatement of those rates would be retroactive to Jan. 1, 2024, and would remain in place through Dec. 31, 2024.

When the visits were all done, Ike had met with elected officials and/or their staff from Alabama, Washington, Iowa, Illinois, Utah, Arizona, Texas, Michigan, South Dakota, Montana, Kentucky, New York, and Wyoming. A focus was to meet with members of Senate Finance, the House Energy and Commerce Committee, the House Ways & Means Committee, and Appropriations.

Through this barnstorming trip, two common themes emerged:

Both bills are in the best place that they can be.
Due to the great work of VGM members and other industry partners, S. 1294 and H.R. 5555 are positioned as well as possible to be included in final packages. 

There is still a long way to go.
While our bills are well positioned, the path forward for each is still undecided. As congress works through negotiations, and a myriad of domestic and global challenges, the consensus of the visit points to a lot of work needing to be done to get the bills across the finish line.

As of yesterday, Congress passed another Continuing Resolution, pushing final votes out into March. While our bills are still very much alive, this does delay the process and continues to put businesses in a challenging spot with the reduced reimbursement staying in place until the final vote. We continue to be assured that the Centers for Medicare and Medicaid will be able to retroactively pay claims when/if the DMEPOS Relief bills pass in a final package.

“In each office I visited, it was clear that our members voices have been heard," said Isaacson. "Each person I talked to was well acquainted with the bills, and the need to provide reimbursement relief that will allow people to receive the services that they need. At this point, the challenges are procedural, but it is clear that we must remain focused on keeping our voices ‘top of mind’ for our elected officials.”

Now is the time to reach out and remind your congressional members just how important these bills are to your business and for the people that you serve. Share the effects of the rate reductions on your ability to serve your community. Keeping this issue “top of mind” is very important, a simple email, letter, or phone call will continue the momentum of support we are getting.

Your VGM Government and Regulatory Team will continue to keep you updated as more information becomes available.

You can act now by going to the VGM Action Center!  Thank you for your work, thank you for your voice, and thank you for being a Champion of Change.

From Our Experts

Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse thumbnail Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse This week, the Trump administration, through the Centers for Medicare & Medicaid Services (CMS), announced a significant deferral of federal Medicaid matching funds to Minnesota alongside the release of a new Request for Information (RFI) tied to the administration's Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) initiative. These actions along with the changes to DMEPOS accreditation and enrollment signal the administration's aggressive posture on Medicaid and Medicare... VGM Response To CMS Moratorium On New DMEPOS Provider thumbnail VGM Response To CMS Moratorium On New DMEPOS Provider The federal moratorium on new DME suppliers presents a defining moment for us as an industry—an opportunity to demonstrate that the VGM members serving patients are the gold standard. We have long shown that our members operate with integrity, excellence in compliance, and unmatched commitment to service, efficiency, and patient outcomes. Now, we must elevate that message. Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium thumbnail Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium In a press release published on the CMS website Feb. 25, 2026, it was announced that CMS will implement a six-month moratorium on new enrollments for DMEPOS suppliers. Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases thumbnail Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases The DME Medicare Administrative Contractors (MACs) issued a proposed Local Coverage Determination (LCD) change for seat elevation use on group 2 non-complex power wheelchair bases (K0830, K0831 and K0108 on group 2 non-complex HD bases). John Quinlan Named 2026 Van G. Miller Homecare Champion thumbnail John Quinlan Named 2026 Van G. Miller Homecare Champion AAHomecare announced earlier this week that John Quinlan of Quinlan's Pharmacy in New York has been selected as the recipient of this year's Van G. Miller Award. John has been a valued VGM member for many years, and his leadership within the DMEPOS community has made a meaningful impact on patients, providers, and the industry as a whole. His commitment to quality care, patient access, and industry advocacy consistently sets him apart. Legislative Update On DMEPOS Bills – Letter To CMS Admin Dr. Oz To Delay Competitive Bidding Program thumbnail Legislative Update On DMEPOS Bills – Letter To CMS Admin Dr. Oz To Delay Competitive Bidding Program Many of you have already contacted your legislators in support of key DME legislation, including the DMEPOS Relief Act, the Choices for Increased Mobility Act, and the Supplemental Oxygen Access Reform (SOAR) Act. We now have another important issue to bring to your attention. CMS Revises Nebulizer Policy and ABN Form thumbnail CMS Revises Nebulizer Policy and ABN Form CMS has issued an update regarding revisions to the CMS Nebulizer Policy Article and guidance on the Advanced Beneficiary Notice of Noncoverage (ABN) Form. For dates of service on or after Feb. 1, 2026, suppliers must include the KX, GA, or GZ modifier to claims for the following nebulizer items: CMS Releases Updated Telehealth FAQ After Funding Bill Extends Flexibilities Through 2027 thumbnail CMS Releases Updated Telehealth FAQ After Funding Bill Extends Flexibilities Through 2027 Earlier this week, Congress extended Medicare telehealth flexibilities through Dec, 31, 2027, as part of the newly signed federal funding bill. In response, CMS has released updated Telehealth Frequently Asked Questions (FAQ) to provide clarity on what the extension means for both patients and providers.